| Histone deacetylases (HDACs): characterization of the classical HDAC family AJM Ruijter, AH GENNIP, HN Caron, S Kemp, ABP KUILENBURG Biochemical Journal 370 (3), 737-749, 2003 | 4024 | 2003 |
| The Concise Guide To Pharmacology 2017/18 DJA Alexander SP, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD ... Br J Pharmacol 174 (Suppl 1), S1-S16, 2017 | 637* | 2017 |
| X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management M Engelen, S Kemp, M De Visser, BM van Geel, RJA Wanders, ... Orphanet journal of rare diseases 7, 1-14, 2012 | 598 | 2012 |
| ABCD1 mutations and the X‐linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations S Kemp, A Pujol, HR Waterham, BM Van Geel, CD Boehm, GV Raymond, ... Human mutation 18 (6), 499-515, 2001 | 377 | 2001 |
| The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 315 | 2017 |
| X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects S Kemp, J Berger, P Aubourg Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (9 …, 2012 | 315 | 2012 |
| Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy S Kemp, HM Wei, JF Lu, LT Braiterman, MC McGuinness, AB Moser, ... Nature medicine 4 (11), 1261-1268, 1998 | 298 | 1998 |
| N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. AH Schinkel, S Kemp, M Dolle, G Rudenko, E Wagenaar Journal of Biological Chemistry 268 (10), 7474-7481, 1993 | 269 | 1993 |
| Fatty acid omega‐oxidation as a rescue pathway for fatty acid oxidation disorders in humans RJA Wanders, J Komen, S Kemp The FEBS journal 278 (2), 182-194, 2011 | 268 | 2011 |
| Adrenoleukodystrophy–neuroendocrine pathogenesis and redefinition of natural history S Kemp, IC Huffnagel, GE Linthorst, RJ Wanders, M Engelen Nature Reviews Endocrinology 12 (10), 606-615, 2016 | 254 | 2016 |
| The concise guide to pharmacology 2019/20: Transporters SPH Alexander, E Kelly, A Mathie, JA Peters, EL Veale, JF Armstrong, ... British journal of pharmacology 176, S397-S493, 2019 | 247 | 2019 |
| Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy S Fourcade, J Lopez-Erauskin, J Galino, C Duval, A Naudi, M Jove, ... Human molecular genetics 17 (12), 1762-1773, 2008 | 243 | 2008 |
| Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot–Marie–Tooth disease type 1B T Kulkens, PA Bolhuis, RA Wolterman, S Kemp, S te Nijenhuis, ... Nature genetics 5 (1), 35-39, 1993 | 236 | 1993 |
| X-linked adrenoleukodystrophy in women: a cross-sectional cohort study M Engelen, M Barbier, IME Dijkstra, R Schür, RMA de Bie, C Verhamme, ... Brain 137 (3), 693-706, 2014 | 233 | 2014 |
| Peroxisomes, lipid metabolism and lipotoxicity RJA Wanders, S Ferdinandusse, P Brites, S Kemp Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2010 | 229 | 2010 |
| X-linked adrenoleukodystrophy: genes, mutations, and phenotypes KD Smith, S Kemp, LT Braiterman, JF Lu, HM Wei, M Geraghty, G Stetten, ... Neurochemical research 24, 521-535, 1999 | 225 | 1999 |
| X-linked adrenoleukodystrophy: pathogenesis and treatment M Engelen, S Kemp, BT Poll-The Current neurology and neuroscience reports 14, 1-8, 2014 | 202 | 2014 |
| The role of ELOVL1 in very long‐chain fatty acid homeostasis and X‐linked adrenoleukodystrophy R Ofman, IME Dijkstra, CWT van Roermund, N Burger, M Turkenburg, ... EMBO molecular medicine 2 (3), 90-97, 2010 | 178 | 2010 |
| Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry F Valianpour, JJM Selhorst, LEM van Lint, AH van Gennip, RJA Wanders, ... Molecular genetics and metabolism 79 (3), 189-196, 2003 | 175 | 2003 |
| A novel defect of peroxisome division due to a homozygous non-sense mutation in the PEX11β gene MS Ebberink, J Koster, G Visser, F van Spronsen, I Stolte-Dijkstra, ... Journal of medical genetics 49 (5), 307-313, 2012 | 155 | 2012 |
Marc EngelenAmsterdam University Medical CentersE-mail confirmado em amc.uva.nl